In this podcast, we talk about new directions in CME — and how to address the continuing need for social learning and perceived authority even as we make information more consumable.
Early involvement of Medical Affairs can be valuable to R&D by providing medical insights from HCPs to influence the TPP, go/no go decision, and optimize the clinical development program. Some biopharma organizations are hiring pipeline MSLs reporting to a Medical Affairs lead within the R&D organization to support clinical trial enrollment efforts and bring the voice of the customer to asset decisions. Defining disease areas of interest is also crucial, involving understanding diseases for which an emerging technology may have an application and determining the existing unmet medical need. Additionally, clarifying the patient journey informs the TPP, clinical feasibility of planned trials, and selection of clinical trial endpoints.
During the webinar, we will discuss considerations for the appropriate structure, resources, and timing to get Medical Affairs involved early enough in the process to optimize clinical development plans informed by medical customer insights. We will also have a dialogue around how early involvement of Medical Affairs can influence which indications should be pursued for a label versus investigator-initiated research.
In this podcast, we explore machine learning as a way to get information about an audience.
The online webinar titled "Medical Operations: Making the Strategy Work" will delve into the critical aspects of how medical operations are instrumental in realizing overall medical strategy. The webinar will highlight the role of medical operations as an innovation hub, showcasing its significance in driving advancements within Medical Affairs. Additionally, the session will emphasize the importance of collaborative partnerships across the entire company, illustrating how such collaborations enable the achievement of better patient outcomes. Attendees can expect valuable insights into the strategic functions of medical operations and how they contribute to the overall success of Medical Affairs.
Through our lens into real-world issues that affect equitable use of industry innovations, Medical Affairs can drive the transformation of industry from a drug-centric perspective to a patient-centric perspective. This article discusses a few of these opportunities.
This introduction to implementation science offers Medical Affairs professionals a 4-step scientific approach for accelerating the adoption of evidence-based care into practice.
In this podcast, we dive into a really important area that can significantly influence your GenAI results – Prompt Engineering and other areas.
As the dust starts to settle around the hype with Generative AI, we believe that the opportunity is right before us to get truly “human-like” understanding at scale. Gen AI allows a unique ability to convert unstructured data into structured information, glean insights and then create a variety of medical content in a myriad of formats.
The webinar will showcase results from use of Generative AI in medical information, content generation and insights. It will also focus on stance taken by industry bodies Journals, Societies, ISMPP [International Society of Publications Professionals] and Regulators in releasing guidance to their members.
It will conclude by taking a crystal ball to look at how the future is unfolding with an ecosystem of models and technologies.
By the end of this webinar, attendees should have a better understanding of use-cases of Generative AI in Medical Affairs and will see results to help inform thinking and build a future roadmap.
This webinar will focus on the role of Medical Affairs to lead patient engagement in clinical development.
Health literacy is experiencing new challenges, and Medical Affairs is uniquely positioned to lead and partner with others in this space to ensure coordination, credibility and impact.